# [BCL6]

## Mutation tier

|Entity|Tier|
|------|----|
|BL    |2   |
|DLBCL |1   |
|FL    |1   |

## Mutation incidence

|Entity|study                |frequency (%)|
|------|---------------------|-------------|
|BL    |GAMBL genomes+capture| 5.08        |
|BL    |Thomas cohort        | 3.40        |
|BL    |Panea cohort         | 7.90        |
|DLBCL |GAMBL genomes        |13.30        |
|DLBCL |Schmitz cohort       | 9.80        |
|DLBCL |Reddy cohort         | 6.40        |
|DLBCL |Chapuy cohort        | 5.10        |
|FL    |GAMBL genomes        | 5.77        |

## Mutation pattern

|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
|------|----|---------------------|----------------|----------------|
|BL    |Yes |No                   | 7.427          | 0.000          |
|DLBCL |Yes |Yes                  |25.672          |60.803          |
|FL    |Yes |Yes                  |27.215          |62.162          |

## aSHM regions

|chr_name|hg19_start|hg19_end |region      |regulatory_comment|
|--------|----------|---------|------------|------------------|
|chr3    |187458526 |187464632|TSS         |NA                |
|chr3    |187615533 |187625659|Intergenic-1|NA                |
|chr3    |187625659 |187638101|Intergenic-2|NA                |
|chr3    |187657518 |187665996|Intergenic-3|NA                |
|chr3    |187675741 |187690717|Intergenic-4|NA                |
|chr3    |187690717 |187705000|Intergenic-5|NA                |

> [!NOTE]
> First described in BL in 2019 by [Grande BM](https://pubmed.ncbi.nlm.nih.gov/30617194). First described in DLBCL in 2011 by [Morin RD](https://pubmed.ncbi.nlm.nih.gov/21796119). First described in FL in 2023 by [Dreval K](https://pubmed.ncbi.nlm.nih.gov/37084389)